Array Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

ARRY 3.65 -0.11 (-2.93%)
price chart
Rising Pharmaceutical Companies: Array BioPharma Inc(NASDAQ:ARRY ...
Array BioPharma Inc(NASDAQ:ARRY) gained eleven cents to move to a new closing price of $3.75, a 3.02% increase in value from the previous closing price.
Related articles »  
Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes ...
Array BioPharma Inc.'s stock finished Friday's session 0.79% lower at $3.76. A total of 2.82 million shares were traded, which was above its three months average volume of 1.48 million shares.
Related articles »  
Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare ...
BOULDER, Colo., Sept. 3, 2014 /PRNewswire/ -- Array BioPharma Inc. ARRY, +0.26% today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York City.
Related articles »  
Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer
11, 2014 /PRNewswire/ -- Array BioPharma Inc. ARRY, -0.79% a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced the appointment of ...
Related articles »  
Today's Hot List: Array BioPharma (NASDAQ:ARRY), Halliburton (NYSE:HAL ...
Array BioPharma Inc. (NASDAQ:ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, announced the appointment of Victor Sandor, M.D.
Small Cap Stocks in a bear Hug: Array Biopharma Inc (ARRY), Basic Energy ...
Array Biopharma Inc (NASDAQ:ARRY) reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014.
Related articles »  
Watch List - Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Array Biopharma Inc ...
Las Vegas, NV - September 22, 2014 - (TechSonian) - Anacor Pharmaceuticals Inc (NASDAQ:ANAC) recently declared its financial results for the quarter ended June 30, 2014.
Array BioPharma Inc.: Array BioPharma Reports Financial Results For The ...
BOULDER, Colo. , Aug. 12, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014 .
Related articles »  
Watch List: Array BioPharma (NASDAQ:ARRY), Renren Inc. (NYSE:RENN), TC ...
On 12 AUG Array BioPharma, Inc. (NASDAQ:ARRY) announced its earnings results on Tuesday. The company reported ($0.22) earnings per share for the quarter, beating the analysts' consensus estimate of ($0.23) by $0.01.
Related articles »  
Best Stocks : Array BioPharma (NASDAQ:ARRY), Hewlett-Packard Company ...
On SEP 3, Array BioPharma Inc. (NASDAQ:ARRY) announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York City, Wednesday, September 10, 2014, 12:55 p.m.
Related articles »